Entellus Medical, Inc. (NASDAQ GM: ENTL)


The firm is investigating potential legal claims against the board of directors of Entellus Medical, Inc. (“Entellus” or the “Company”) (NASDAQ GM: ENTL) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Stryker Corporation (“Stryker”) (NYSE: SYK) in a transaction valued at approximately $662 million. Under the terms of the agreement, shareholders of Entellus will receive $24.00 in cash for each share of Entellus common stock.

If you are a current shareholder and would like to discuss your options of exercising your rights as a shareholder, which include ensuring that the company is getting the highest possible price for the company, and that the board of directors will act in the best interest of the shareholders, please contact us.

Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.

Personal Information
Name:
Phone #:
E-mail Address:
Stock Information
Do you currently own the stock? Yes   No
Purchase Date:
Quantity Purchased:
Purchase Price Per Share:

Please Note: Neither the submission to nor the receipt of information by The Law Offices of Marc S. Henzel or one of its attorneys through this website constitutes an agreement by the firm to represent the individual and does not create an attorney-client relationship.